124.554 Rules and reporting.
1. The board and advisory council shall jointly adopt rules in accordance with chapter 17A to carry out the purposes of, and to enforce the provisions of, this subchapter. The rules shall include but not be limited to the development of procedures relating to:
a. Identifying each patient about whom information is entered into the program.
b. An electronic format for the submission of information from pharmacies and prescribing practitioners.
c. A waiver to submit information in another format for a pharmacy or prescribing practitioner unable to submit information electronically.
d. An application by a pharmacy or prescribing practitioner for an extension of time for transmitting information to the program.
e. The submission by an authorized requestor of a request for information and a procedure for the verification of the identity of the requestor.
f. Use by the board or advisory council of the program request records required by section 124.553, subsection 2, to document and report statistical information.
g. Including all schedule II, schedule III, and schedule IV controlled substances, schedule V controlled substances including when dispensed by a pharmacist without a prescription except for sales of pseudoephedrine that are reported to the real-time electronic repository, opioid antagonists, and other prescription substances that the advisory council and board determine can be addictive or fatal if not taken under the proper care and direction of a prescribing practitioner.
h. Access by a pharmacist or prescribing practitioner to information in the program pursuant to a written agreement with the board and advisory council.
i. The correction or deletion of erroneous information in the program.
j. The issuance annually of a prescribing practitioner activity report compiled from information from the program pursuant to subsection 3.
k. The establishment of thresholds or other criteria or measures to be used in identifying an at-risk patient as provided in section 124.553, subsection 1, paragraph “g”, and the targeted distribution of proactive notifications suggesting review of the patient’s prescription history.
2. Beginning February 1, 2021, and annually by February 1 thereafter, the board and advisory council shall present to the general assembly and the governor a report prepared consistent with section 124.555, subsection 3, paragraph “d”, which shall include but not be limited to the following:
a. The cost to the state of implementing and maintaining the program.
b. Information from pharmacies, prescribing practitioners, the board, the advisory council, and others regarding the benefits or detriments of the program.
c. Information from pharmacies, prescribing practitioners, the board, the advisory council, and others regarding the board’s effectiveness in providing information from the program.
3. a. Annually by February 1, the board shall electronically, and at as low a cost as possible, issue each prescribing practitioner who prescribed a controlled substance reported to the program as dispensed in the preceding calendar year in this state a prescribing practitioner activity report which shall include but not be limited to the following:
(1) A summary of the prescribing practitioner’s history of prescribing controlled substances.
(2) A comparison of the prescribing practitioner’s history of prescribing controlled substances with the history of other prescribing practitioners of the same profession or specialty.
(3) The prescribing practitioner’s history of program use.
(4) General patient risk factors.
(5) Educational updates.
(6) Other pertinent information identified by the board and advisory council by rule.
b. Information provided to a prescribing practitioner in a report required under this subsection is privileged and shall be kept confidential pursuant to section 124.553, subsection 3.
2006 Acts, ch 1147, §5, 11; 2007 Acts, ch 126, §29, 30; 2017 Acts, ch 54, §76; 2018 Acts, ch 1138, §7, 14, 15, 20; 2020 Acts, ch 1024, §4 – 6
Referred to in §124.551, 124.552, 124.553, 124.555, 124.556
Structure Iowa Code
Chapter 124 - CONTROLLED SUBSTANCES
Section 124.101 - Definitions.
Section 124.101A - Administration of controlled substances — delegation.
Section 124.101B - Factors indicating an imitation controlled substance.
Section 124.201 - Duty to recommend changes in schedules — temporary amendments to schedules.
Section 124.201A - Cannabis-derived products — rules.
Section 124.202 - Controlled substances — listed regardless of name.
Section 124.203 - Substances listed in schedule I — criteria.
Section 124.204 - Schedule I — substances included.
Section 124.205 - Substances listed in schedule II — criteria.
Section 124.206 - Schedule II — substances included.
Section 124.207 - Substances listed in schedule III — criteria.
Section 124.208 - Schedule III — substances included.
Section 124.209 - Substances listed in schedule IV — criteria.
Section 124.210 - Schedule IV — substances included.
Section 124.211 - Schedule V — criteria.
Section 124.212 - Schedule V — substances included.
Section 124.212B - Pseudoephedrine sales — tracking — penalty.
Section 124.212C - Pseudoephedrine advisory council — electronic monitoring.
Section 124.213 - Pseudoephedrine purchase restrictions from pharmacy or retailer — penalty.
Section 124.302 - Registration requirements.
Section 124.303 - Registration.
Section 124.304 - Revocation, suspension, or restriction of registration.
Section 124.305 - Contested case proceedings.
Section 124.306 - Records of registrants.
Section 124.307 - Order forms.
Section 124.308 - Prescriptions.
Section 124.401C - Manufacturing methamphetamine in presence of minors.
Section 124.401G - Iowa hemp Act — negligent violation program.
Section 124.402 - Prohibited acts — distributors — registrants — proprietors — penalties.
Section 124.404 - Penalties under other laws.
Section 124.405 - Bar to prosecution.
Section 124.406 - Distribution to person under age eighteen.
Section 124.406A - Use of persons under age eighteen in the drug trade.
Section 124.407 - Gatherings where controlled substances unlawfully used — penalties.
Section 124.408 - Joint criminal trials.
Section 124.409 - Conditional discharge, commitment for treatment, and probation.
Section 124.410 - Accommodation offense.
Section 124.411 - Second or subsequent offenses.
Section 124.412 - Notice of conviction.
Section 124.413 - Mandatory minimum sentence — parole eligibility.
Section 124.414 - Drug paraphernalia.
Section 124.415 - Parental and school notification — persons under eighteen years of age.
Section 124.416 - Exception to restrictions on bail.
Section 124.417 - Imitation controlled substances — exceptions.
Section 124.418 - Persons seeking medical assistance for drug-related overdose.
Section 124.501 - Responsibility for enforcement.
Section 124.502 - Administrative inspections and warrants.
Section 124.503 - Injunctions.
Section 124.504 - Cooperative arrangements and confidentiality.
Section 124.506 - Controlled substances — disposal.
Section 124.506A - Large seizure of a controlled substance — evidence and disposal.
Section 124.507 - Burden of proof — liabilities.
Section 124.508 - Judicial review.
Section 124.509 - Education and research.
Section 124.510 - Reports of arrests and analyses to department.
Section 124.550 - Definitions.
Section 124.551 - Information program for drug prescribing and dispensing.
Section 124.551A - Prescribing practitioner program registration.
Section 124.552 - Information reporting.
Section 124.553 - Information access.
Section 124.554 - Rules and reporting.
Section 124.555 - Advisory council established.
Section 124.556 - Education and treatment.
Section 124.557 - Drug information program fund — surcharge.
Section 124.558 - Prohibited acts — penalties.